Display Settings:

Format

Send to:

Choose Destination
    Genes Dev. 2010 Aug 1;24(15):1574-9.

    Antisense oligonucleotides and spinal muscular atrophy: skipping along.

    Source

    Department of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, Ohio 43210, USA. Burghes.1@osu.edu

    Abstract

    Antisense oligonucleotides (ASOs) can be used to alter the splicing of a gene and either restore production of a required protein or eliminate a toxic product. In this issue of Genes & Development, Hua and colleagues (pp. 1634-1644) show that ASOs directed against an intron splice silencer (ISS) in the survival motor neuron 2 (SMN2) gene alter the amount of full-length SMN transcript in the nervous system, restoring SMN to levels that could correct spinal muscular atrophy (SMA).

    PMID:
    20679391
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2912553
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1.

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk